The Israel-based Sharon Laboratories, a leading global innovator and manufacturer of preservative solutions for cosmetics and personal care markets, will acquire the cosmetic ingredients unit of Gorla Minore, Italy-based B&C S.p.A., as well as the company’s research and innovation unit, CR&D.

Founded in 2007, B&C produces a unique line of bio-active ingredients that bring added value to cosmetic brands and consumers, with a strong focus on skin benefits and wellness.

The Company develops natural and sustainable ingredients, offering excipients and green phytoactive substances, such as delivery systems, emulsifiers and emollients. CR&D is a subsidiary of B&C, and it serves as the company’s dedicated research and development arm. It is responsible for the organization’s innovation and technology development.

The closing for the acquisition is subject to the completion of certain conditions and is expected to be completed during the second quarter of 2022. Following completion of the acquisition, B&C’s cosmetic unit and its CR&D research subsidiary will be integrated into Sharon Laboratories’ business.

This acquisition, which follows Sharon Laboratories’ announcement of the Res Pharma Industriale acquisition, will allows the Company to expand its cosmetic ingredients portfolio and enhance its focus on green, natural and sustainable technology.